A portfolio company can look healthy on a revenue chart while carrying significant commercial risk. Recent growth may depend on the founder, a few exceptional sellers or a handful of large accounts. Pipeline numbers may look strong while deal progression is inconsistent. The business may be recruiting ahead of a sales process it has not yet proved can scale.
Investors cannot operate every portfolio company's sales function, nor should they. But they can ask questions that distinguish a repeatable commercial engine from a collection of promising results.
These seven questions are designed to sharpen that conversation. They are not a substitute for full commercial diligence, but they can quickly reveal where further examination would create value.
1. Can you explain exactly why customers buy from you?
A compelling market narrative is not the same as a repeatable sales proposition. Ask the CEO which customer segments convert most consistently, what triggers the buying decision and why customers choose this solution rather than an alternative or the status quo.
Look for evidence beyond the founder's conviction. Are the strongest use cases understood by the whole sales team? Is there a clear relationship between customer problem, value delivered and willingness to pay? Do win-loss reviews confirm the story?
If the answer changes depending on which executive is asked, the business may not have a stable basis for scaling its go-to-market investment.
2. How much of your pipeline is genuinely qualified?
Pipeline coverage ratios can be useful, but only when the underlying opportunities are credible. An apparent multiple of the target offers little comfort if close dates are speculative, stakeholders are unknown and deals sit inactive for months.
Ask how the organisation defines qualification, what evidence is required to progress a deal and how frequently opportunities are disqualified. Examine a sample of records, not just the dashboard. A business willing to remove weak opportunities from its pipeline may be demonstrating greater maturity than one reporting the largest headline number.
Pay particular attention to concentration. If the current quarter depends on three major opportunities, the quality of management around those deals becomes a board-level issue.
3. What explains your conversion rates?
It is tempting to judge commercial performance through a single win rate. That misses the point. Conversion needs to be understood between meaningful stages and across customer segments, channels and deal types.
Ask whether the company knows where prospects commonly disengage. Are too many proposals issued after weak discovery? Do opportunities stall during procurement? Are salespeople struggling to access economic buyers? Is price resistance actually a failure to establish business value?
The objective is not to demand a universally high conversion percentage. Different sales motions produce different economics. The question is whether leadership understands the drivers and has a plan to improve them.
4. How reliable is the forecast—and why?
A forecast should represent evidence about customer decisions, not a negotiation between the board's ambition and the sales team's confidence.
Compare successive forecasts with actual outcomes. Track deals that slip and ask when their risks became visible. Does the CEO receive early warning, or do material changes emerge in the closing weeks? Does the sales manager inspect buying steps and stakeholder commitment, or simply collect verbal assurances?
Repeated misses may reflect commercial process, management capability or market conditions. The investor's task is to distinguish these causes before imposing an arbitrary uplift on next quarter's target.
5. Could this business grow without the founder closing deals?
Founder-led selling is often essential to reaching product-market fit. It becomes a constraint when the company expects growth to outpace the founder's capacity.
Ask which steps in the sales motion depend on the founder's relationships, authority or product knowledge. Can hired sellers diagnose customer problems and handle commercial negotiations independently? Is there a documented approach to qualification, deal progression and onboarding?
The right answer is not necessarily to remove the founder from selling immediately. They may remain important for strategic accounts. What matters is whether the business has a deliberate route from personal selling to organisational capability.
6. What return are you getting on sales capacity?
Adding headcount does not automatically create proportional revenue. The return depends on the availability of qualified demand, the effectiveness of onboarding, territory design, sales cycle length and management quality.
Ask for cohort-based evidence where available: time to productivity, attainment distribution, pipeline creation, retained performance and reasons for underperformance. Does leadership understand whether the next growth constraint is capacity or productivity?
If sellers are underutilised because the top of the funnel is weak, recruitment may amplify costs. If demand is strong but conversion suffers, additional headcount may not solve the issue. Investment should follow a clear bottleneck diagnosis.
7. What would break if revenue doubled?
This question moves the discussion from current achievement to operating resilience.
Would sales management still work? Could the company onboard sellers effectively? Would the CRM and reporting support more complex deals? Can Marketing create sufficient qualified demand? Would customer implementation or success teams absorb the additional business?
Ask the CEO to identify the two or three capabilities most likely to constrain growth and the sequence in which they intend to address them. A credible plan acknowledges trade-offs. An unconvincing one assumes every function can scale at the same rate without changing how it operates.
Turn the answers into a useful operating agenda
These questions become valuable when they produce action rather than another lengthy board pack.
Start by identifying the material uncertainties. Perhaps the company has credible market demand but inconsistent qualification. Perhaps the sales team converts well, but founder dependence will prevent scale. Perhaps the revenue plan assumes a rate of hiring and ramp that the business has never demonstrated.
Agree which issues need immediate investigation, what data will resolve them and who will own the next decision. A time-bound Commercial Performance Review can establish the facts, rank constraints and outline a practical improvement sequence. In other cases, the right response may be interim leadership or a focused execution project.
Crucially, the intervention should be proportional to the need. A profitable company with one forecasting weakness does not necessarily require a complete commercial transformation.
How investors and operating specialists collaborate
Operating partners bring a portfolio-wide perspective, governance influence and a clear understanding of investment priorities. A specialist sales operator can provide granular inspection of the commercial system: discovery quality, pipeline discipline, management cadence, hiring capability and execution risks.
The combination creates an opportunity to connect board-level objectives with what actually happens in customer conversations and sales management meetings. It also helps avoid a common mistake: assuming that a missed target is solely a sales personnel issue when the underlying problem may be segmentation, process or commercial leadership.
For portfolio businesses preparing for a funding event, international expansion or exit, that clarity can be particularly valuable. Better revenue quality is about the repeatability and visibility of performance, not just a stronger growth narrative.
The most important question
The seven questions can be distilled into one: “What evidence gives us confidence that this business can produce its next phase of revenue predictably?”
A CEO who can answer with coherent metrics, customer evidence and a realistic operating plan gives investors more to work with than one who relies on ambition alone.
